Dow Down 0.37% Nasdaq Up 0.55%

Seattle Genetics Inc. (SGEN)

-NasdaqGS
35.33 Up 0.68(1.96%) 10:05AM EDT - Nasdaq Real Time Price
Prev Close:34.65
Open:34.65
Bid:35.26 x 300
Ask:35.36 x 100
1y Target Est:44.92
Beta:2.2
Next Earnings Date:30-Oct-14SGEN Earnings announcement
Day's Range:34.65 - 35.47
52wk Range:30.80 - 55.99
Volume:110,250
Avg Vol (3m):1,013,940
Market Cap:4.36B
P/E (ttm):N/A
EPS (ttm):-0.60
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SGEN

Comparison

Symbol% ChgMkt Cap
SGENUp 1.96%4.36B
IMGNUp 9.64%781.75M
PFEDown 0.29%175.96B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):15.56
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.81
Quarterly EPS Est (Sep-14) :-0.24
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):8.73

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. The company is developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback